The tumour–stroma ratio in colon cancer: the biological role and its prognostic impact

Gabi W. van Pelt, Wilma E. Mesker(Leiden University Medical Center), Tessa P. Sandberg(Leiden University), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Hans Morreau(Leiden University Medical Center), J. Han van Krieken(Radboud University Nijmegen), Hans Gelderblom(Leiden University Medical Center)
Histopathology
February 21, 2018
10.1111/his.13489
Cited by 161

Related Papers

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k